Pharmaceutical Applications of Shellac: Moisture-Protective and Taste-Masking Coatings and Extended-Release Matrix Tablets

2003 ◽  
Vol 29 (8) ◽  
pp. 925-938 ◽  
Author(s):  
N. Pearnchob ◽  
J. Siepmann ◽  
R. Bodmeier
2019 ◽  
Vol 9 (01) ◽  
pp. 27-33
Author(s):  
Naveen Kumar ◽  
Sonia Pahuja ◽  
Ranjit Sharma

Humans have taken advantage of the adaptability of polymers for centuries in the form of resins, gums tars, and oils. However, it was not until the industrial revolution that the modern polymer industry began to develop. Polymers represent an important constituent of pharmaceutical dosage forms. Polymers have played vital roles in the formulation of pharmaceutical products. Polymers have been used as a major tool to manage the drug release rate from the formulations. Synthetic and natural-based polymers have found their way into the biomedical and pharmaceutical industries. Synthetic and Natural polymers can be produced with a broad range of strength, heat resistance, density, stiffness and even price. By constant research into the science and applications of polymers, they are playing an ever-increasing role in society. Diverse applications of polymers in the present pharmaceutical field are for controlled drug release. Based on solubility pharmaceutical polymers can be classified as water-soluble and water-insoluble. In general, the desirable polymer properties in pharmaceutical applications are film forming, adhesion, gelling, thickening, pH-dependent solubility and taste masking. General pharmaceutical applications of polymers in various pharmaceutical formulations are also discussed


2010 ◽  
Vol 37 (1) ◽  
pp. 80-87
Author(s):  
Nizar Al-Zoubi ◽  
Kyriakos Kachrimanis ◽  
Khaled Younis ◽  
Stavros Malamataris

2014 ◽  
Vol 50 (2) ◽  
pp. 291-300 ◽  
Author(s):  
Guilherme Neves Ferreira ◽  
Marcos Giovani Rodrigues Silva ◽  
Aline Guerra Manssour Fraga ◽  
Luiz Cláudio Rodrigues Pereira da Silva ◽  
Luiz Marcelo Lira ◽  
...  

Reproducibility of the tablet manufacturing process and control of its pharmaceutics properties depends on the optimization of formulation aspects and process parameters. Computer simulation such as Design of Experiments (DOE) can be used to scale up the production of this formulation, in particular for obtaining sustained-release tablets. Bromopride formulations are marketed in the form of extended-release pellets, which makes the product more expensive and difficult to manufacture. The aim of this study was to formulate new bromopride sustained release formulations as tablets, and to develop mathematical models to standardize the scale up of this formulation, controlling weight and hardness of the tablets during manufacture according to the USP 34th edition. DOE studies were conducted using Minitab(tm) software. Different excipient combinations were evaluated in order to produce bromopride sustained-release matrix tablets. In the scale-up study, data were collected and variations in tableting machine parameters were measured. Data were processed by Minitab(tm) software, generating mathematical equations used for prediction of powder compaction behavior, according to the settings of the tableting machine suitable for scale-up purposes. Bromopride matrix tablets with appropriate characteristics for sustained release were developed. The scale-up of the formulation with the most suitable sustained release profile was established by using mathematical models, indicating that the formulation can be a substitute for the pellets currently marketed.


2016 ◽  
Vol 24 (1) ◽  
pp. 82-91 ◽  
Author(s):  
Kwabena Ofori-Kwakye ◽  
Kwadwo Amanor Mfoafo ◽  
Samuel Lugrie Kipo ◽  
Noble Kuntworbe ◽  
Mariam El Boakye-Gyasi

Sign in / Sign up

Export Citation Format

Share Document